University of Eastern Finland: Glucocorticoid Receptor is a Double-edged Sword in Prostate Cancer
June 15, 2025
June 15, 2025
KUOPIO, Finland, June 15 (TNSjou) -- The University of Eastern Finland issued the following news:
* * *
The glucocorticoid receptor is a double-edged sword in prostate cancer
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.
Glucocorticoids are steroid hormones that are also used as . . .
* * *
The glucocorticoid receptor is a double-edged sword in prostate cancer
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.
Glucocorticoids are steroid hormones that are also used as . . .